miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma

• Lucía Trilla-Fuertes ,

  Contributed equally to this work with: Lucía Trilla-Fuertes, Natalia Miranda

  Roles Conceptualization, Formal analysis, Writing – original draft

  Affiliation Biomedica Molecular Medicine SL, Madrid, Spain

  http://orcid.org/0000-0002-4452-3474

  ⨯
• Natalia Miranda ,

  Contributed equally to this work with: Lucía Trilla-Fuertes, Natalia Miranda

  Roles Conceptualization, Data curation, Writing – original draft

  Affiliation Urology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

  ⨯
• Daniel Castellano,

  Roles Conceptualization, Data curation, Supervision

  Affiliation Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

  ⨯
• Rocío López-Vacas,

  Roles Methodology

  Affiliation Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Carlos A. Farfán Tello,

  Roles Data curation

  Affiliations Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain, Clínica Internacional S.A., Lima, Perú

  ⨯
• Guillermo de Velasco,

  Roles Conceptualization, Data curation

  Affiliation Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

  ⨯
• Felipe Villacampa,

  Roles Conceptualization, Data curation

  Affiliation Urology Department, Clínica Universidad de Navarra, Madrid, Spain

  ⨯
• Elena López-Camacho,

  Roles Methodology

  Affiliation Biomedica Molecular Medicine SL, Madrid, Spain

  ⨯
• Guillermo Prado-Vázquez,

  Roles Formal analysis

  Affiliations Biomedica Molecular Medicine SL, Madrid, Spain, Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Andrea Zapater-Moros,

  Roles Formal analysis

  Affiliations Biomedica Molecular Medicine SL, Madrid, Spain, Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain, Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain

  ⨯
• Enrique Espinosa,

  Roles Supervision, Writing – review & editing

  Affiliations Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain, Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain

  ⨯
• Juan Ángel Fresno Vara,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliations Biomedica Molecular Medicine SL, Madrid, Spain, Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain, Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain

  ⨯
• Álvaro Pinto ,

  Roles Supervision, Writing – review & editing

  * E-mail: alvaropintomarin@gmail.com (AP); angelogamez@gmail.com (AG-P)

  Affiliation Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain

  ⨯
• Angelo Gámez-Pozo

  Roles Conceptualization, Formal analysis, Supervision, Writing – review & editing

  * E-mail: alvaropintomarin@gmail.com (AP); angelogamez@gmail.com (AG-P)

  Affiliations Biomedica Molecular Medicine SL, Madrid, Spain, Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  http://orcid.org/0000-0002-8931-0624

  ⨯